Diabetic dyslipidaemiaBETTERIDGE, D. J.European journal of clinical investigation. Supplement. 1999, Vol 29, Num 2, pp 12-16, issn 0960-135XConference Paper

Lipids, diabetes, and vascular disease: the time to actBETTERIDGE, D. J.Diabetic medicine. 1989, Vol 6, Num 3, pp 195-218, issn 0742-3071Article

International multicentre comparison of cerivastatin with placebo and simvastatin for the treatment of patients with primary hypercholesterolaemiaBETTERIDGE, D. J.International journal of clinical practice (Esher). 1999, Vol 53, Num 4, pp 243-250, issn 1368-5031Article

Prandial Glucose Regulation: Proceedings of a Workshop, Nice, France, 8-10 May 1998BETTERIDGE, D. J.European journal of clinical investigation. Supplement. 1999, Vol 29, Num 2, issn 0960-135X, 39 p.Conference Proceedings

Thiazolidinediones and fracture risk in patients with Type 2 diabetesBETTERIDGE, D. J.Diabetic medicine. 2011, Vol 28, Num 7, pp 759-771, issn 0742-3071, 13 p.Article

Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetesBETTERIDGE, D. J; VERGES, B.Diabetologia (Berlin). 2005, Vol 48, Num 12, pp 2477-2481, issn 0012-186X, 5 p.Article

Platelet function, platelet prostanoids and vascular prostacyclin in diabetes mellitusHENDRA, T; BETTERIDGE, D. J.Prostaglandins, leukotrienes and essential fatty acids. 1989, Vol 35, Num 4, pp 197-212, issn 0952-3278, 16 p.Article

Diabetic dyslipidemiaBETTERIDGE, D. J.The American journal of medicine. 1994, Vol 96, Num 6A, pp 6A.25-6A.31S, issn 0002-9343Conference Paper

The interplay of cardiovascular risk factors in the metabolic syndrome and type 2 diabetesBETTERIDGE, D. J.European heart journal supplements. 2004, Vol 6, Num G, pp G3-G7, issn 1520-765XConference Paper

Repaglinide : a new short-acting insulinotropic agent for the treatment of Type 2 diabetesOWENS, D. R.European journal of clinical investigation. Supplement. 1999, Vol 29, Num 2, pp 30-37, issn 0960-135XConference Paper

Lipids, lipoproteins, and coronary heart disease: implications for antihypertensive therapyFEHER, M. D; BETTERIDGE, D. J.Cardiovascular drugs and therapy. 1989, Vol 3, pp 333-340, suppl.1Article

Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetesBETTERIDGE, D. J; GIBSON, J. M.Diabetic medicine. 2007, Vol 24, Num 5, pp 541-549, issn 0742-3071, 9 p.Article

Repaglinide, a new oral antidiabetic agent : a review of recent preclinical studiesMALAISSE, W. J.European journal of clinical investigation. Supplement. 1999, Vol 29, Num 2, pp 21-29, issn 0960-135XConference Paper

Diabetic dyslipidaemia: treatment implicationsBETTERIDGE, D. J.Journal of internal medicine. Supplement. 1994, Vol 236, Num 736, pp 47-52, issn 0955-7873Article

Current therapeutic options in Type 2 diabetesHEINE, R. J.European journal of clinical investigation. Supplement. 1999, Vol 29, Num 2, pp 17-20, issn 0960-135XConference Paper

Comparative efficacy and safety of ciprofibrate and sustained-release bezafibrate in patients with type II hyperlipidaemiaBETTERIDGE, D. J; O'BRYAN-TEAR, C. G.Postgraduate medical journal. 1996, Vol 72, Num 854, pp 739-743, issn 0032-5473Article

What is oxidative stress?BETTERIDGE, D. J.Metabolism, clinical and experimental. 2000, Vol 49, Num 2, pp 3-8, issn 0026-0495, SUP1Conference Paper

Prandial glucose regulation and cardiovascular disease in Type 2 diabetesKUUSISTO, J; LAAKSO, M.European journal of clinical investigation. Supplement. 1999, Vol 29, Num 2, pp 7-11, issn 0960-135XConference Paper

Lipids and thrombosisGASSER, J. A; BETTERIDGE, D. J.Baillière's clinical endocrinology and metabolism. 1990, Vol 4, Num 4, pp 923-938, issn 0950-351X, 16 p.Article

New approaches to managing multiple risk factors in cardiovascular diseaseERHARDT, L. R; BETTERIDGE, D. J.European heart journal supplements. 2004, Vol 6, Num G, issn 1520-765X, 19 p.Conference Proceedings

The current management of diabetic dyslipidaemiaBETTERIDGE, D. J.Acta diabetologica (Print). 2001, Vol 38, pp S15-S19, issn 0940-5429, SUP1Conference Paper

Reduced platelet serotonin content and release in familial hypercholesterolaemiaSMITH, C. C. T; BETTERIDGE, D. J.Atherosclerosis. 1997, Vol 130, Num 1-2, pp 87-92, issn 0021-9150Article

Lipids and atherogenesis in diabetes mellitusBETTERIDGE, D. J.Atherosclerosis. 1996, Vol 124, pp S43-S47, issn 0021-9150, SUPConference Paper

Cholesterol consensus : α trans-atlantic perspective. Round-table conferenceBARTH, J. D; BETTERIDGE, D. J.International journal of cardiology. 1992, Vol 37, issn 0167-5273, 54 p., SUP1Conference Proceedings

Glucose metabolism and the postprandial stateLEFEBVRE, P. J; SCHEEN, A. J.European journal of clinical investigation. Supplement. 1999, Vol 29, Num 2, pp 1-6, issn 0960-135XConference Paper